Hasantari, I.; Nicolas, N.; Alzieu, P.; Leval, L.; Shalabi, A.; Grolleau, S.; Dinet, V.
Factor H’s Control of Complement Activation Emerges as a Significant and Promising Therapeutic Target for Alzheimer’s Disease Treatment. Int. J. Mol. Sci. 2024, 25, 2272.
https://doi.org/10.3390/ijms25042272
AMA Style
Hasantari I, Nicolas N, Alzieu P, Leval L, Shalabi A, Grolleau S, Dinet V.
Factor H’s Control of Complement Activation Emerges as a Significant and Promising Therapeutic Target for Alzheimer’s Disease Treatment. International Journal of Molecular Sciences. 2024; 25(4):2272.
https://doi.org/10.3390/ijms25042272
Chicago/Turabian Style
Hasantari, Iris, Nabil Nicolas, Philippe Alzieu, Léa Leval, Andree Shalabi, Sylvain Grolleau, and Virginie Dinet.
2024. "Factor H’s Control of Complement Activation Emerges as a Significant and Promising Therapeutic Target for Alzheimer’s Disease Treatment" International Journal of Molecular Sciences 25, no. 4: 2272.
https://doi.org/10.3390/ijms25042272
APA Style
Hasantari, I., Nicolas, N., Alzieu, P., Leval, L., Shalabi, A., Grolleau, S., & Dinet, V.
(2024). Factor H’s Control of Complement Activation Emerges as a Significant and Promising Therapeutic Target for Alzheimer’s Disease Treatment. International Journal of Molecular Sciences, 25(4), 2272.
https://doi.org/10.3390/ijms25042272